> Products > CAS NO 796848-80-1

China CAS NO 796848-80-1 Factory

We have now a specialist, efficiency staff to provide good quality company for our consumer. We normally follow the tenet of customer-oriented, details-focused for CAS NO 796848-80-1,796848-80-1,Lenvatinib intermediate,Lenvatinib advance intermediate,phenyl 2-chloro-4-hydroxyphenylcarbaMate, With superb service and quality, and an enterprise of foreign trade featuring validity and competitiveness, that will be trusted and welcomed by its clients and creates happiness to its employees.
CAS NO 796848-80-1, Only for accomplishing the good-quality product to meet customer's demand, all of our products have been strictly inspected before shipment. We always think about the question on the side of the customers, because you win, we win!

Hot Products

4-BROMO-2-TRIFLUOROMETHYLPYRIDINE
Product Name:4-BROMO-2-TRIFLUOROMETHYLPYRIDINE
Molecular Formula:C6H3BrF3N
Molecular Weight:225.99
CAS Registry Number:887583-90-6
Cenobamate
Product Name:Cenobamate
Molecular Formula:C10H10ClN5O2
Molecular Weight;267.67
CAS Registry Number;913088-80-9
Fmoc-Cys(Trt)-OH
Product Name:Fmoc-Cys(Trt)-OH
Molecular Formula:C37H31NO4S
Molecular Weight:585.71
CAS Registry Number:103213-32-7
N-(1-Oxohexadecyl)-L-glutaMic Acid tert-Butyl Ester
Product Name:N-(1-Oxohexadecyl)-L-glutaMic Acid tert-Butyl Ester
Molecular Formula:C25H47NO5
Molecular Weight:441.64
CAS Registry Number:536721-25-2
4-(Trifluoromethyl)benzaldehyde
Product Name:4-(Trifluoromethyl)benzaldehyde
Molecular Formula:C8H5F3O
Molecular Weight:174.12
CAS Registry Number:455-19-6
CERIUM(III) CHLORIDE
Product Name:CERIUM(III) CHLORIDE
Molecular Formula:CeCl3
Molecular Weight:246.48
CAS Registry Number:7790-86-5

Related Blog
Reviews

What is an Active Pharmaceutical Ingredient (API in Pharma)?
Sandoo Pharmaceutical is a professional active pharmaceutical intermediate manufacturer, producing high quality APIs. Sandoo Pharmaceutical provides a wide range of active pharmaceutical intermediates.
FDA approves lorlatinib for second- or third-line treatment of ALK-positive metastatic NSCLC
On November 2, 2018, the Food and Drug Administration granted accelerated approval to lorlatinib (LORBRENA, Pfizer, Inc.) for patients with anaplastic lymphoma kinase (ALK)-positive metastatic non-small cell lung cancer (NSCLC) whose disease has progressed on crizotinib and at least one other ALK inhibitor for metastatic disease or whose disease has progressed on alectinib or ceritinib as the first ALK inhibitor therapy for metastatic disease.
Differences Between Pharmaceutical Raw Materials, Excipients and Pharmaceutical Intermediates
In the pharmaceutical industry, there are various names of raw materials, such as pharmaceutical raw materials, pharmaceutical intermediates and pharmaceutical excipients in the process of pharmaceutical production. This article will take everyone to recognize these three concepts.
Bosutinib CAS 380843-75-4
Chemical name:4-(2,4-dichloro-5-methoxyanilino)-6-methoxy-7-[3-(4-methylpiperazin-1-yl)propoxy]quinoline-3-carbonitrile
What is the difference between API and FDF in pharma？
In the pharmaceutical industry, you might hear the terms “FDF” and “API” frequently used in reference to products. We surely understand this type of jargon, but we certainly can see how the general public would feel overwhelmed looking at those kinds of terminology abbreviations. This article is for explaining the difference between API and FDF. For reference, they mean, respectively, “finished dosage form” and “active pharmaceutical ingredient.”
Pharmaceutical Intermediates Manufacturers - Something You Need to Know About Pharma Intermediates Industry
Pharmaceutical intermediates are actually chemical raw materials or chemical products that need to be used in the synthesis of drugs. Such chemical products...

China CAS NO 796848-80-1 Factory

Related Products

Hot Products

4-BROMO-2-TRIFLUOROMETHYLPYRIDINE

Cenobamate

Fmoc-Cys(Trt)-OH

N-(1-Oxohexadecyl)-L-glutaMic Acid tert-Butyl Ester

4-(Trifluoromethyl)benzaldehyde

CERIUM(III) CHLORIDE

What is an Active Pharmaceutical Ingredient (API in Pharma)?

FDA approves lorlatinib for second- or third-line treatment of ALK-positive metastatic NSCLC

Differences Between Pharmaceutical Raw Materials, Excipients and Pharmaceutical Intermediates

Bosutinib CAS 380843-75-4

What is the difference between API and FDF in pharma？

Pharmaceutical Intermediates Manufacturers - Something You Need to Know About Pharma Intermediates Industry

Marcy Real 2023-04-13 17:34:00

Susan 2022-06-21 17:54:33

Afra 2023-03-07 12:27:19

Rosemary 2023-08-30 03:23:51

Marguerite 2023-11-06 17:48:02

Georgia 2023-11-07 02:32:40

Send Inquiry